Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation
Learn what manufacturing changes trigger FDA re-evaluation for generic drugs, how PAS submissions work, and how to avoid costly delays. Key triggers include facility transfers, scale-up, new suppliers, and formulation changes.